# FDA Inspection 1314436 - KedPlasma LLC - April 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/8d421bb0-e3f0-4196-a2b4-f9f68f0b29aa
Source feed: FDA_Inspections

> FDA Inspection 1314436 for KedPlasma LLC on April 21, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314436
- Company Name: KedPlasma LLC
- Inspection Date: 2026-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1298204 - 2026-01-08](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/05b25ef6-d917-46b9-8ff0-31868c6249f4)
- [FDA Inspection 1294768 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/7377c7df-0f3d-48c3-997c-ddaf06493b5c)
- [FDA Inspection 1285778 - 2025-10-09](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/2a34bd53-2950-47f3-a615-f77fdc2e917f)
- [FDA Inspection 1219073 - 2023-07-24](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/28b8c805-f23e-47f9-8712-410ccd18c022)

Company: https://www.keypedia.com/companies/kedplasma-llc/9ec4a061-8bd5-4de8-b996-0e59e2824ef9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d